Nonetheless, future research undertakings should incorporate ICI biomarkers, including PD-L1 expression and tumor mutational burden, to assess the indispensable role of pre-existing adaptive immunity in facilitating effective FMT 270,271. Here, CD274 is linked to neoplasm.